Categories
Connect with us on LinkedIn
Castor collaborates with Microsoft to bring Practical AI to clinical trials.
Today, Castor announces its collaboration with Microsoft to integrate Practical AI in clinical trials, reducing trial burdens for...
2023: Castor Year in Review
As we close the year, the Castor team shares vital milestones the company has achieved to make patient-centric...
The AI Hype and Reality: Key Highlights from CNS Summit 2023
At this year's CNS Summit, Castor achieved a remarkable feat by winning the AI Demo Awards. Watch more...
10 FAQs on eConsent
To gain a deeper understanding of eConsent, we have gathered the 10 most frequently asked questions that address...
Don’t Overengineer It: Hybrid Designs Overcome Barriers in DTx Clinical Trials
At DTxEast 2023, Castor joined a panel discussion to answer big questions when designing DTx clinical trials
Understand Barriers to eConsent Adoption from Site and Sponsor Perspectives
Decentralized technologies are transforming clinical trials by addressing patient recruitment and engagement challenges.
Navigating successful eConsent adoption from sponsor to site
Our on demand webinar with Leanne Walsh from Northern Light Lifescience to dive into the process of eConsent...
Harnessing the power of Patient-centric Technologies
Decentralized technologies are transforming clinical trials by addressing patient recruitment and engagement challenges.
Castor announces Frans van Houten, former CEO of Philips, as the company’s new chairman of its Board Of Directors
His exceptional leadership experience and extensive industry knowledge in the healthcare and technology industries will be invaluable to...
Preparing Your eConsent Study for IRB Approval
In this blog we cover how eConsent benefits trials and aligns with IRB ethical commitments, how to prepare...
Castor welcomes Jeanne Hecht to Board of Directors
Castor, an industry leader in modular, patient-centric, clinical trial technology, today announced the appointment of Jeanne Hecht to...
AI & Air Hockey – What to expect at DIA?
Listen to our CEO & Founder, Derk Arts, as he reflects on lessons learned from the BIO panel...
The role of patient-centric technologies & tokenization in RWE studies
In this on-demand webinar we join forces with UBC & Datavant to dive deep into patient-centric technologies &...
Considerations for the use of RWE in FDA Assessments
As the adoption of real-world evidence (RWE) in healthcare continues to grow, and with the FDA embracing these...
Improving Your Consent Process with Generative AI
As the adoption of real-world evidence (RWE) in healthcare continues to grow, and with the FDA embracing these...
Real-World Evidence: The Importance of Standardization & Democratization
As the adoption of real-world evidence (RWE) in healthcare continues to grow, and with the FDA embracing these...
Castor announces appointment of Brad Hightower, leading clinical trials executive, to its advisory board
Castor announces the appointment of Brad Hightower, a leading clinical trials executive, to its advisory board.
2023 Making a Positive Impact
As we kick-off 2023 with a refreshed mindset, we take inventory of what is important and focus on...
Connect with us on LinkedIn
